ABSTRACT: 

Background: Drug induced gingival enlargement is frequently observed in patients taking three main group of drugs like calcium channel blockers (CCBs), immunosuppressant’s and anticonvulsants. Amlodipine belongs to the dihydropyridine-a third generation calcium channel blockers agents that may cause the side effect of drug-induced gingival enlargement and oral bacteria intervention due to calculus retention. This case report describes the management of gingival enlargement in a hypertensive patient taking amlodipine.
Purpose: This case report was aimed to discuss the treatment and maintenance of systemic observationsurgical periodontic approach to restore gingival enlargement.
Case Report: A 47-years old man was referred to the Department of Periodontology, Faculty of Dentistry, Airlangga University complaining of swellings and bleeding on his gingiva in all region. He felt very uncomfortable as the swelling interfered while chewing and sometimes there was bleeding spontaneously and halitosis. He had hypertension since 5 years and was on medications Captopril 12,5 mg daily during 4 years and Amlodipine 5mg daily during last 1 year. A provisional diagnosis and systemic observation-periodontal phases treatment were taken to restore gingival enlargement condition.
Case Management: Systemic observation of medication use, periodontal phases treatment such as scaling root planning, periodontal surgery as flap surgery, home oral hygiene maintenance, control recall every month during first 3 months were taken.
Conclusion: The successful of combination carefully systemic observation-surgery periodontal approach are promising to maintain Amlodipine induced gingival enlargement.

KEYWORDS:

Amlodipine, Gingival enlargement, Systemic observation, Surgical periodontic

REFERENCES :

1) The prevalence, risk factors, pathogenesis, and clinical management of drug-associated gingival enlargement. Drug- Associated Gingival Enlargement. J Periodontol 2004;75:1424-1431
2) Kaur G, Verhamme KMC, Dieleman JP, Vanrolleghem A, van Soest EM, Strick BHCh, Sturkenboom MCJM. Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol 2010;37: 625–630. doi:10.1111/j.1600- 051X.2010.01574.x.
3) Upadhyay Y. Amlodipine-Induced Gingival Overgrowth: A Case Report. IOSR Journal of Dental and Medical Sciences (JDMS. Volume 3, Issue 4 (Jan.- Feb.2013),PP 17-20. www.iosrjournals.org.
4) Seymour, R. A., Ellis, J. S., Thomason, J. M., Monkman, S. &
Idle, J. R. (1994) Amlodipine- induced gingival overgrowth. Journal of Clinical Periodontology 21, 281–283.
5) Barclay S, Thomason JM, Idle JR and Seymour RA. (1992). The incidence and severity of nifedipineinduced gingival overgrowth. J Clin Periodontol, 19: 311-314.
6) Ikawa K, Ikawa M, Shimauchi H, Iwakura M and Sakamoto S (2002). Treatment of gingival overgrowth induced by manidipine administration: a case report. J Periodontol, 72: 115-122.
7) Taib Ha, Ali TBTb, Kamin Sb .Case Report – Amlodipine-induced gingival overgrowth: a case report. Archives of Orofacial Sciences (2007) 2, 61-64